Can You Help ASCs Access the Latest Medtech Advances?
Ambulatory surgery centers (ASCs) are helping healthcare payers reduce costs and improve patient outcomes, Scott Leggett, CEO of Surgery One LLC, an ASC management company that works with outpatient surgical centers, told MD+DI. Outpatient surgical centers are quick to adopt new medical device technologies, he said, but they do have some tech needs that medical device manufacturers could help address. ASCs are poised for “huge” growth, Leggett predicted. “Any procedures now being done in hospitals for qualified outpatient candidates are being encouraged to be performed ...
Source: MDDI - April 20, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news

Watch the Birdie: Badminton Players at Risk for Eye Injuries Watch the Birdie: Badminton Players at Risk for Eye Injuries
Badminton players may be at high risk for serious eye injuries, many of which can bring on permanent vision problems or blindness, according to a study of wounds treated at a Beijing hospital.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 19, 2019 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Pulse Pressure Better Than Systolic BP for Predicting Severe Diabetic Retinopathy Pulse Pressure Better Than Systolic BP for Predicting Severe Diabetic Retinopathy
Pulse pressure (PP), the difference between systolic and diastolic blood pressure, is a better predictor of severe diabetic retinopathy than is systolic blood pressure, researchers from Japan report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 19, 2019 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

National Hand Hygiene Initiative Successful in Australia
Overall hand hygiene compliance increased from 2009 to 2017; associated drop seen in HA - SAB incidence (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 19, 2019 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Loan Forgiveness, Educational Debt May Affect Practice Patterns
Graduates with loan forgiveness/repayment program more likely to enter primary care fields (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 19, 2019 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Indiana Legislature Stopped Optometrists' Competition in the Blink of An Eye
An innovative online eye test is banned in Indiana, not because it is unsafe, but because entrenched interests convinced lawmakers to ban it in a 2016 law. Now, they are fighting back in court against protectionism. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 18, 2019 Category: Pharmaceuticals Authors: Andrew Wimer, Contributor Source Type: news

A Gene Therapy Breakthrough Could Offer a Treatment for the Rare and Deadly ‘Bubble Boy’ Disease
Researchers used an experimental gene therapy to develop a possible treatment for a rare and deadly immune disorder known as “bubble boy” disease, the National Institutes of Health (NIH) announced Wednesday. Because of a gene mutation, babies who are born with X-linked severe combined immunodeficiency (X-SCID) do not develop immune cells properly, leaving them highly susceptible to infections. The condition, which strikes up to one in 50,000 newborns, primarily affects boys and requires extreme measures to prevent infection. In one famous case, a boy with SCID, David Vetter, lived in a sterile plastic “bu...
Source: TIME: Health - April 18, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Research Source Type: news

Watch the birdie: Badminton players at risk for eye injuries
(Reuters Health) - Badminton players may be at high risk for serious eye injuries, many of which can bring on permanent vision problems or blindness, according to a study of wounds treated at a Beijing hospital. (Source: Reuters: Health)
Source: Reuters: Health - April 18, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

OHSU study offers hope for people with multiple sclerosis
In multiple sclerosis, the immune system eats away at the sheath that protects the nerves, disrupting signals between the brain and the body and causing problems in walking and eyesight. No drugs have ever been developed to restore that protective layer, called myelin. But a study out Thursday from Oregon Health& Science University offers some hope. Researchers found myelin repair is possible, though their method has not yet been tested in humans. The potential game changer is a compound called… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 18, 2019 Category: American Health Authors: Elizabeth Hayes Source Type: news

Thirst regulates motivated behavior through modulation of brainwide neural population dynamics
Physiological needs produce motivational drives, such as thirst and hunger, that regulate behaviors essential to survival. Hypothalamic neurons sense these needs and must coordinate relevant brainwide neuronal activity to produce the appropriate behavior. We studied dynamics from ~24,000 neurons in 34 brain regions during thirst-motivated choice behavior in 21 mice as they consumed water and became sated. Water-predicting sensory cues elicited activity that rapidly spread throughout the brain of thirsty animals. These dynamics were gated by a brainwide mode of population activity that encoded motivational state. After sati...
Source: ScienceNOW - April 18, 2019 Category: Science Authors: Allen, W. E., Chen, M. Z., Pichamoorthy, N., Tien, R. H., Pachitariu, M., Luo, L., Deisseroth, K. Tags: Neuroscience r-articles Source Type: news

5 Myths About Dry Eye Disease 5 Myths About Dry Eye Disease
Is your knowledge about dry eye disease'all dried up'? Dr Brianne Hobbs busts 5 myths about this common eye condition.Medscape Ophthalmology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 17, 2019 Category: Allergy & Immunology Tags: Ophthalmology Article Source Type: news

Teprotumumab, Canagliflozin, and Kevin Pho Top AACE Agenda Teprotumumab, Canagliflozin, and Kevin Pho Top AACE Agenda
Graves'ophthalmopathy, type 2 diabetes treatment, social media matters, and much more to be featured at Los Angeles conference.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 16, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Glaukos ’ iStent Has Strong Showing in 5-Year Data
This study shows that not only are Glaukos’ iStents as effective as once-daily topical travoprost in controlling IOP, but they also succeed at maintaining IOP reductions over the long-term with fewer additional medications.” The San Clemente, CA-based company has been on full court press for a while now. Earlier this year, at the 37th annual J.P. Morgan Healthcare Conference, the company unveiled a series of products and initiatives that would see it transition into a hybrid surgical, pharmaceutical, and medical device company.     (Source: MDDI)
Source: MDDI - April 16, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

First U.S. Patients Treated With CRISPR As Human Gene-Editing Trials Get Underway
This could be a crucial year for the powerful gene-editing technique CRISPR as researchers start testing it in patients to treat diseases such as cancer, blindness and sickle cell disease.(Image credit: Molekuul/Getty Images/Science Photo Library) (Source: NPR Health and Science)
Source: NPR Health and Science - April 16, 2019 Category: Consumer Health News Authors: Rob Stein Source Type: news

Scientists Plan To Start Human Trials Testing CRISPR Soon
The powerful gene-editing technique is moving out of the lab and into the clinic. Trials will use CRISPR to try to treat a variety of diseases, ranging from cancer and blindness to blood disorders. (Source: NPR Health and Science)
Source: NPR Health and Science - April 16, 2019 Category: Consumer Health News Authors: Rob Stein Source Type: news

Glaukos touts 5-year study of glaucoma stents
This study shows that not only are Glaukos’ iStents as effective as once-daily topical travoprost in controlling IOP, but they also succeed at maintaining IOP reductions over the long-term with fewer additional medications.” Three-year outcomes of this study were published in 2016 in Ophthalmology and Therapy. The most recent article detailing five-year outcomes may be accessed online here. “This latest publication represents the first-ever five-year, protocol-driven, randomized evaluation of standalone iStent implantation in newly diagnosed glaucoma patients,” said Glaukos prez & CEO Thomas Bur...
Source: Mass Device - April 15, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Featured Implants News Well Optical/Ophthalmic Vision Glaukos Ivantis Source Type: news

How Common Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

How Commonly Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

British scientists say they're on the cusp of curing blindness with stem cell treatment
There is no cure for retinitis pigmentosa, an inherited condition that slowly constricts vision, but a British firm has reported early success with a procedure to repair a damaged retina. (Source: the Mail online | Health)
Source: the Mail online | Health - April 14, 2019 Category: Consumer Health News Source Type: news

Prednisolone Acetate 1% Ophthalmic Suspension (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 11, 2019 Category: Drugs & Pharmacology Source Type: news

Domestic Responsibilities Tied to Physician Mothers ’ Satisfaction
Being responsible for at least five tasks linked to desire to change career for moms in procedural specialties (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 11, 2019 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Second Sight Medical releases early feasibility data on Orion cortical implant
Second Sight Medical (NSDQ:EYES) today announced preliminary results from a small feasibility study of its Orion cortical implant, which is designed to give eyesight to the blind. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal and translates it to the visual cortex in the brain, bypassing the eye and the optic nerve entirely. The company’s Argus II device, which uses a retinal implant to receive the camera’s signal, is already on the U.S. market. Interim data from a five-year early feasibility study, prese...
Source: Mass Device - April 11, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Featured Optical/Ophthalmic Second Sight Source Type: news

How sci-fi beams saved my eyesight by zapping cancer
A YOUNG sportsman has told how his sight was saved by a pioneering cancer treatment machine "like something out of science fiction". (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2019 Category: Consumer Health News Source Type: news

Latanoprost Ophthalmic Solution 0.005% (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 10, 2019 Category: Drugs & Pharmacology Source Type: news

Avaclyr (Acyclovir Ophthalmic Ointment) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 10, 2019 Category: Drugs & Pharmacology Source Type: news

Medtronic taps Lennon as CIO | Personnel Moves – April 9, 2018
Medtronic (NYSE:MDT) said that it named Sean Lennon as its new chief information officer, set to take effect April 29. The Fridley, Minn.-based medtech giant said that Lennon will take over for Mike Hedges, who is retiring from the position after 19 years with Medtronic, including 10 as CIO. Prior to joining Medtronic, Lennon served as CIO with Allergan (NYSE: AGN), the company said. He has previously held senior leadership positions with pharmaceutical companies including Watson/Actavis, Novartis (NYSE:NVS) and Schering-Plough.  Clearside Biomedical appoints Lasezkay as interim CEO Clearside Biomedical...
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Allergan Clearside Biomedical ICU Medical Inc. iHear Medical LifeScan Inc. lumenxt Medtronic Novartis OptiScan oregonbioscienceassociation Owens & Minor Shape Memory Therapeutics SynCard Source Type: news

Hyacinths could lead to a cure for blindness, scientists say
Researchers at Surrey University say they could, in the future, create synthetic versions of the potent compounds to develop sight-saving treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2019 Category: Consumer Health News Source Type: news

High-Dose Steroids: Worth the Risk in Bacterial Keratitis? High-Dose Steroids: Worth the Risk in Bacterial Keratitis?
Dr Christopher Rapuano on why, despite its limitations, a new study provides convincing evidence that this treatment approach is warranted.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 9, 2019 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Nature could provide the answer for blindness caused by diabetes, say experts
(University of Surrey) Mother Nature could have the answer to treating several causes of blindness, according to a ground-breaking study involving scientists from the University of Surrey and the Eugene and Marilyn Glick Eye Institute at Indiana University School of Medicine in the USA. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2019 Category: International Medicine & Public Health Source Type: news

Man, 74, is left with a bulging white mass coming out of his EYE after undergoing cataract surgery
The 74-year-old - who has not been named - was referred to a cancer-ophthalmology clinic at Duke University, North Carolina, when a 10x10mm lump formed where his pupil should be. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2019 Category: Consumer Health News Source Type: news

Ask What Is an Ophthalmoplegic Migraine
What Is an Ophthalmoplegic Migraine? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 8, 2019 Category: General Medicine Source Type: news

Dozens of Clinics Market Risky Cell Therapies to Treat Eye Disorders Dozens of Clinics Market Risky Cell Therapies to Treat Eye Disorders
Scores of clinics across the United States directly advertise expensive - but unproven - stem cell therapies to patients with serious eye diseases, often with devastating results, a new study warns.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 5, 2019 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Presbia delays Flexivue Microlens FDA PMA approval timeline again
Presbia (NSDQ:LENS) has delayed the timeline for approval of its Flexivue Microlens for treating far-sightedness again due to an earlier request for more information from the FDA. The Irvine, Calif.-based company was told last October that it had 180 days to provide the agency with 36-month data from all subjects enrolled in the staged pivotal clinical trial, as well as additional safety and efficacy information, before it can complete its premarket approval application review, according to an SEC filing. Presbia submitted its final pre-market approval module to the FDA during the second quarter of last year, includin...
Source: Mass Device - April 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Pre-Market Approval (PMA) Regulatory/Compliance Presbia Source Type: news

Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
A new study published in Investigative Ophthalmology & Visual Science suggests that artificial intelligence (AI) could be used to provide widespread, cost-effective eye screenings via telemedicine to assist ophthalmologists in improving vision outcomes for people with diabetes. The study looks at diabetic macular edema (DME), which is a leading cause of vision loss among working-age adults. “DME currently impacts approximately 10 percent of the 425 million people around the world living with diabetes, and this is expected to increase,” said Jeff Willis, M.D., Ph.D., assoc...
Source: MDDI - April 4, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Digital Health Source Type: news

Radiology Techs Assisting With Fluoroscopy May Risk Cataracts Radiology Techs Assisting With Fluoroscopy May Risk Cataracts
Radiology technicians who assist with fluoroscopically guided interventional procedures (FGIP) are at higher risk of cataract, new research suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 4, 2019 Category: Orthopaedics Tags: Ophthalmology News Source Type: news

College research raises awareness of dementia that has early visual symptoms
The College of Optometrists has completed research on the experiences of vision assessment for people living with a form of dementia that impacts vision. (Source: NHS Networks)
Source: NHS Networks - April 4, 2019 Category: UK Health Source Type: news

‘Revolutionary’ treatment may prevent blindness: Scientists discover way of boosting stem cells
Stem cells in the cornea stiffen and work less effectively after eye injuries such as acid attacks like the one suffered by Katie Piper (pictured), scientists at Newcastle University said. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2019 Category: Consumer Health News Source Type: news

FDA accepts second application for Ocular Therapeutix ’ s drug-delivering implant
Ocular Therapeutix (NSDQ:OCUL) said today that the FDA has accepted a new supplemental New Drug Application for its Dextenza, an ocular insert designed to release dexamethasone to relieve pain following ophthalmic surgery. The Bedford, Mass.-based company’s device is designed to deliver drugs for up to 30 days following treatment in a physician’s office. Ocular Therapeutix is positioning its product as a way to eliminate the current standard of care for post-surgical pain – topical steroid eye drops. Read the whole story on our sister site, Drug Delivery Business News (Source: Mass Device)
Source: Mass Device - April 3, 2019 Category: Medical Devices Authors: Fink Densford Tags: Drug-Device Combinations Featured Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance oculartherapeutix Source Type: news

Over - the - Counter Meds Save Health Care System Money
OTC medicines lead to $ 146 billion in annual clinical and drug cost savings (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 2, 2019 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Testosterone May Underlie Rare Blindness Condition in Women Testosterone May Underlie Rare Blindness Condition in Women
Idiopathic intracranial hypertension, a condition which can lead to blindness and primarily affects obese women, may be the result of increased testosterone levels in the blood and CSF, say UK researchers.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 2, 2019 Category: Emergency Medicine Tags: Diabetes & Endocrinology News Source Type: news

Bausch and Lomb Announces the U.S. Launch of LOTEMAX(R) SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% for the Treatment of Postoperative Inflammation and Pain Following Ocular Surgery
Shipments to U.S. Pharmaceutical Distributors Begin BRIDGEWATER, N.J., April 2, 2019 -- (Healthcare Sales & Marketing Network) -- Bausch & Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: ... Biopharmaceuticals, Ophthalmology, Surgery, Product Launch Bausch & Lomb, Bausch Health Companies, LOTEMAX, loteprednol etabonate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2019 Category: Pharmaceuticals Source Type: news

IStent Inject Device Lowers IOP After Cataract Surgery in Glaucoma Patients IStent Inject Device Lowers IOP After Cataract Surgery in Glaucoma Patients
In patients with mild to moderate glaucoma and cataract, the second-generation iStent inject system, with two redesigned stents, reduces intraocular pressure (IOP) more than cataract surgery alone, according to results of a new pivotal trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 2, 2019 Category: Surgery Tags: Ophthalmology News Source Type: news

Contact Lenses That Reduce Eye Itch May Become a Reality Contact Lenses That Reduce Eye Itch May Become a Reality
Experimental contact lenses that not only improve vision, but also ward off itchiness due to allergies, got a boost with the completion of two late-stage studies, according to a new report.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 2, 2019 Category: Allergy & Immunology Tags: Ophthalmology News Source Type: news

Duke adding another private practice into its fold
The Duke Health system is adding another private practice, with the announced partnership with North Carolina Eye, Ear, Nose and Throat (NCEENT). Monday, the Private Diagnostic Clinic – the physician practice of Duke Health – and the Duke Departments of Ophthalmology and Surgery announced a partnership with NCEENT, consolidating its operations into the Duke system. Effective this week, all of NCEENT's five locations with become Duke H ealth practices, and its 14 physicians will become Duke… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2019 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

Duke adding another private practice into its fold
The Duke Health system is adding another private practice, with the announced partnership with North Carolina Eye, Ear, Nose and Throat (NCEENT). Monday, the Private Diagnostic Clinic – the physician practice of Duke Health – and the Duke Departments of Ophthalmology and Surgery announced a partnership with NCEENT, consolidating its operations into the Duke system. Effective this week, all of NCEENT's five locations with become Duke H ealth practices, and its 14 physicians will become Duke… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 2, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

Primary care networks will include pharmacies, optometrists and dental providers
Primary care networks will include community pharmacies, optometrists and dental providers, according to new NHS contract documents.  Networks will be expected to have‘wide-reaching’ membership to offer‘more personalised, coordinated health and social care’ to their local populations, NHS England said in a new primary care network frequently asked questions document. Hide related content:  Show related contentread more (Source: Management in Practice)
Source: Management in Practice - April 2, 2019 Category: Practice Management Authors: Angela Sharda Tags: *** Editor ' s Pick Latest News Source Type: news

Rhopressa (Netarsudil Topical Ophthalmic Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 2, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Approves Avaclyr (acyclovir ophthalmic ointment) for the Treatment of Herpetic Keratitis
NEW YORK–(BUSINESS WIRE) April 01, 2019–The US Food and Drug Administration (FDA) has approved Fera Pharmaceuticals' New Drug Application (NDA) for Avaclyr (acyclovir ophthalmic ointment) 3% for the treatment of herpetic keratitis.... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 2, 2019 Category: Drugs & Pharmacology Source Type: news

Q & A: How Bees Find Your Flowerpots
It ’ s not just the famous waggle dance: Bees rely on sophisticated eyesight and even electrostatic fields. (Source: NYT Health)
Source: NYT Health - April 1, 2019 Category: Consumer Health News Authors: C. CLAIBORNE RAY Tags: Bees Flowers and Plants Pollen Source Type: news

MPR: Getting medical device development back on track
In this podcast, experts from MPR discuss what medical device companies can do if things go sideways during the product development process. Drawing from their own experiences, engineers from the firm spoke with MassDevice.com editor Sarah Faulkner about how they tackle device development challenges when they are called into action. Sarah Faulkner: Hey, everyone. Thanks for downloading this podcast. I’m really excited to bring you this conversation about what to do when things go sideways during the product development process. Faulkner: I spoke with a group of experts from MPR. They’re a product developm...
Source: Mass Device - April 1, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured MPR Source Type: news